MedTrace Logo

Observational Study of LUMRYZ in Narcolepsy

NCT06792708 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 71

Last updated 2026-02-13

No results posted yet for this study

Summary

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

Conditions

Interventions

DRUG

LUMRYZ

Prescribed for narcolepsy in accordance with product label.

Sponsors & Collaborators

  • Avadel

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-18
Primary Completion
2025-10-28
Completion
2025-10-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06792708 on ClinicalTrials.gov